Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Seltzer

Surgery of the Hand Palm Beach Gardens, FL Doctor of Osteopathy

NPI 1124127055 CMS profile 96531

4215 Burns Road, Suite 100, Palm Beach Gardens, FL 33410

Open in the dashboard

General payments

$9,862

80 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Seltzer of Palm Beach Gardens, FL is reported in the CMS Open Payments database as having received $9,862 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,731 16
2024 General $197 5
2023 General $651 14
2022 General $469 10
2021 General $1,285 6
2020 General $90 3
2019 General $3,437 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Seltzer
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Andrew Seltzer were reported at $3,731. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.

Show as a table
Year Andrew Seltzer Surgery of the Hand median Middle half National median
2019 $3,437 $369 $108–$1,516 $163
2020 $90 $153 $56–$898 $114
2021 $1,285 $261 $84–$1,296 $132
2022 $469 $313 $103–$1,562 $149
2023 $651 $241 $95–$876 $160
2024 $197 $236 $84–$890 $164
2025 $3,731 $288 $115–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $3,681 21 payments
  2. Zimmer Biomet Holdings, Inc. $2,549 11 payments
  3. Southern Edge Orthopaedics, Inc. $1,671 3 payments
  4. Smith+Nephew, Inc. $877 13 payments
  5. Stryker Corporation $424 7 payments
  6. Orthofix Medical, Inc. $130 2 payments
  7. Bioventus LLC $91 5 payments
  8. Abbott Laboratories $78 2 payments
  9. Medtronic, Inc. $77 4 payments
  10. Embody, Inc. $71 1 payment
  11. Other $212 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $3,795 4 payments
  2. Food and Beverage $3,587 68 payments
  3. Travel and Lodging $2,480 8 payments
Products named General payments · program years 2019–2025
  1. Persona $1,158 1 payment
  2. EVOS $296 3 payments
  3. ROSA $216 2 payments
  4. mymobility Platform $157 3 payments
  5. MAKO $154 1 payment
  6. Ascension $150 1 payment
  7. Navio Surgical System $144 1 payment
  8. ACCOLADE $138 2 payments
  9. NuGrip CMC Implant System $135 1 payment
  10. Physio-Stim $130 2 payments
  11. Other $938 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

237

Median for Hand Surgery: 118

Drug cost

$1,229

Median for Hand Surgery: $615

Branded share of claims

18.1%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 55 $578
Methylprednisolone Generic 51 $263
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 32 $166
Meloxicam Generic 30 $74
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 11 $56
Promethazine Hcl Generic 25 $49
Tramadol Hcl Generic 33 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 127 billing codes

Paid by Medicare

$296,935

Of which drugs: $55,452

Medicare patients

795

Average age 76

Services billed

9,439

466 women, 329 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 72%
High blood pressure 69%
Ischemic heart disease 32%
Diabetes 25%
Chronic kidney disease 22%
Atrial fibrillation 21%
Osteoporosis 21%
Depression 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg J7322 Office 34 2,045 $28,094
Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg J7331 Office 30 1,941 $16,621
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 382 1,482 $7,663

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record